Bukowska, Joanna
Frazier, Trivia
Smith, Stanley
Brown, Theodore
Bender, Robert
McCarthy, Michelle
Wu, Xiying
Bunnell, Bruce A.
Gimble, Jeffrey M.
Article History
First Online: 18 April 2018
Compliance with Ethical Standards
:
: Xiying Wu and Smith report a patent on use of adipose cells in therapy in the submission process from LaCell LLC.Jeff Gimble is a co-founder and co-owner of Talaria Antibodies, a polyclonal antibody production company; Obatala Sciences, a fat on a chip technology; and is a co-founder, co-owner, and employee at LaCell LLC. Xiying Wu is a co-founder, co-owner, and R&D Director at LaCell LLC; a co-owner and co-founder of Obatala Sciences; and reports a patent on use of adipose cells in therapy in the submission process from LaCell LLC. Stanley Smith reports a patent on use of adipose cells in therapy in the submission process from LaCell LLC. Michelle McCarthy, Trivia Frazier, Joanna Bukowska, Theodore Brown, Robert Bender, and Bruce Bunnell declare no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.